Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Tue, 23 Jul 19 03:19:22 +0000 Tue, 23 Jul 19 03:19:22 +0000 Generic Pregabalin Capsules Receive FDA Approval http://www.pharmacytimes.com/news/generic-pregabalin-capsules-receive-fda-approval http://www.pharmacytimes.com/news/generic-pregabalin-capsules-receive-fda-approval InvaGen&rsquo;s Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg are therapeutically equivalent to Pfizer&#39;s pregabalin capsules (Lyrica). Mon, 22 Jul 19 11:00:00 +0000 Risks of Rocky Mountain Spotted Fever Examined http://www.pharmacytimes.com/news/risks-of-rocky-mountain-spotted-fever-examined http://www.pharmacytimes.com/news/risks-of-rocky-mountain-spotted-fever-examined A binational team of investigators at the University of California, Davis, has conducted the first comprehensive study to examine the risk factors for Rocky Mountain spotted fever in Mexicali, Mexico. They found that citywide, just 1 in 1000 ticks was infected with the disease, but in certain neighborhoods, about 1 in 10 ticks was infected. Thu, 18 Jul 19 15:18:00 +0000 FDA Approves New Antibacterial Combination for Treating Certain Infections in Adults http://www.pharmacytimes.com/news/fda-approves-new-antibacterial-combination-for-treating-certain-infections-in-adults http://www.pharmacytimes.com/news/fda-approves-new-antibacterial-combination-for-treating-certain-infections-in-adults Merck&rsquo;s antibacterial drug injection&mdash;a combination of imipenem, cilastatin and relebactam (Recarbrio) &mdash;is indicated for adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI). Wed, 17 Jul 19 13:39:00 +0000 Pharmacists Can Help Reduce Risk from Extended-Release Acetaminophen --- A Key Potential Confounding Factor in Suspected Overdoses http://www.pharmacytimes.com/news/pharmacists-can-help-reduce-risk-from-extendedrelease-acetaminophen--a-key-potential-confounding-factor-in-suspected-overdoses http://www.pharmacytimes.com/news/pharmacists-can-help-reduce-risk-from-extendedrelease-acetaminophen--a-key-potential-confounding-factor-in-suspected-overdoses Acetaminophen-related overdose continues to be a leading cause of emergency deparment visits and hospitalizations and remains the leading cause of drug-induced acute liver failure in the United States. Mon, 15 Jul 19 15:06:00 +0000 New Treatment for Refractory Multiple Myeloma Granted FDA Approval http://www.pharmacytimes.com/news/new-treatment-for-refractory-multiple-myeloma-granted-fda-approval http://www.pharmacytimes.com/news/new-treatment-for-refractory-multiple-myeloma-granted-fda-approval Selinexor (Xpovio, Karyopharm) tablets in combination with the corticosteroid dexamethasone was approved under the agency&#39;s accelerated approval program. Wed, 03 Jul 19 18:39:00 +0000 Product News: New Label Color for Medication Requiring Special Handling http://www.pharmacytimes.com/news/product-news-new-label-color-for-medication-requiring-special-handling http://www.pharmacytimes.com/news/product-news-new-label-color-for-medication-requiring-special-handling Medi-Dose<sup>&reg;</sup> has created bright yellow Lid-Label<sup>&reg;</sup> Covers for use with our Circular and Oval Medi-Cup<sup>&reg;</sup> Blisters.&nbsp; Tue, 02 Jul 19 12:00:00 +0000 New Formulation of Tiopronin Receives FDA Approval for Treatment of Cystinuria http://www.pharmacytimes.com/news/new-formulation-of-tiopronin-receives-fda-approval-for-treatment-of-cystinuria http://www.pharmacytimes.com/news/new-formulation-of-tiopronin-receives-fda-approval-for-treatment-of-cystinuria Retrophin&#39;s enteric-coated formulation allows administration with or without food. Sat, 29 Jun 19 18:00:00 +0000 FDA Approves Biosimilar to Bevacizumab for Treatment of 5 Cancers http://www.pharmacytimes.com/news/fda-approves-biosimilar-to-bevacizumab-for-treatment-of-5-cancers http://www.pharmacytimes.com/news/fda-approves-biosimilar-to-bevacizumab-for-treatment-of-5-cancers Pfizer&rsquo;s bevacizumab-bvzr (Zirabev) demonstrated clinical equivalence and no clinically meaningful differences compared with the reference product.&nbsp; Fri, 28 Jun 19 14:28:00 +0000 FDA Approves Combo Regimen for New Multiple Myeloma Indication http://www.pharmacytimes.com/news/fda-approves-combo-regimen-for-new-multiple-myeloma-indication http://www.pharmacytimes.com/news/fda-approves-combo-regimen-for-new-multiple-myeloma-indication Daratumumab (Darzalex, Janssen) is indicated for use in combination with lenalidomide and dexamethasone for patients with newly-diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.<br /> &nbsp; Thu, 27 Jun 19 20:08:00 +0000 Eculizumab Receives FDA Approval for Neuromyelitis Optica Spectrum Disorder http://www.pharmacytimes.com/news/eculizumab-receives-fda-approval-for-neuromyelitis-optica-spectrum-disorder http://www.pharmacytimes.com/news/eculizumab-receives-fda-approval-for-neuromyelitis-optica-spectrum-disorder Eculizumab (Soliris) is indicated for adult patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive. Thu, 27 Jun 19 19:51:00 +0000 FDA Expands Use of Avatrombopag for Adults with Chronic Immune Thrombocytopenia http://www.pharmacytimes.com/news/fda-expands-use-of-avatrombopag-for-adults-with-chronic-immune-thrombocytopenia http://www.pharmacytimes.com/news/fda-expands-use-of-avatrombopag-for-adults-with-chronic-immune-thrombocytopenia Avatrombopag was previously approved by the agency for treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure.&nbsp; Thu, 27 Jun 19 13:48:00 +0000 FDA OKs Dupilumab for Chronic Rhinosinusitis with Nasal Polyps http://www.pharmacytimes.com/news/fda-oks-dupilumab-for-chronic-rhinosinusitis-with-nasal-polyps http://www.pharmacytimes.com/news/fda-oks-dupilumab-for-chronic-rhinosinusitis-with-nasal-polyps CRSwNP often occurs with severe asthma and requires systemic steroids or nasal surgery, the current standard of care. Wed, 26 Jun 19 19:40:00 +0000 FDA Issues Warnings to 2 Companies Marketing and Distributing Kratom Products http://www.pharmacytimes.com/news/fda-issues-warnings-to-2-companies-marketing-and-distributing-kratom-products http://www.pharmacytimes.com/news/fda-issues-warnings-to-2-companies-marketing-and-distributing-kratom-products The letters request actions to correct violations cited by the agency. Tue, 25 Jun 19 20:41:00 +0000 AbbVie Agrees to Acquire Allergan with $63B Deal http://www.pharmacytimes.com/news/abbvie-agrees-to-acquire-allergan-with-63b-deal http://www.pharmacytimes.com/news/abbvie-agrees-to-acquire-allergan-with-63b-deal Announced by both companies today, the new combined company will consist of franchises across immunology, hematologic oncology, medical aesthetics, neuroscience, women&rsquo;s health, eye care, and virology. Tue, 25 Jun 19 16:00:00 +0000 Retail Pharmacy Provides More Drug Disposal Options http://www.pharmacytimes.com/news/walgreens-rolls-out-new-drug-disposal-options http://www.pharmacytimes.com/news/walgreens-rolls-out-new-drug-disposal-options In an effort to combat the opioid epidemic, Walgreens has introduced its recently announced an addition to its drug disposal program in the form of DisposeRx packets. Mon, 24 Jun 19 14:00:00 +0000 Tezacaftor/Ivacaftor Receives FDA Approval for Patients Ages 6 and Older with Cystic Fibrosis http://www.pharmacytimes.com/news/tezacaftorivacaftor-receives-fda-approval-for-patients-ages-6-and-older-with-cystic-fibrosis http://www.pharmacytimes.com/news/tezacaftorivacaftor-receives-fda-approval-for-patients-ages-6-and-older-with-cystic-fibrosis This approval expands tezacaftor/ivacaftor&rsquo;s indication to include patients ages 6 and older with cystic fibrosis who have certain genetic mutations.<br /> &nbsp; Fri, 21 Jun 19 18:48:00 +0000 FDA Addresses Benefit-Risk Framework for Evaluating Opioid Analgesics http://www.pharmacytimes.com/news/fda-addresses-benefitrisk-framework-for-evaluating-opioid-analgesics http://www.pharmacytimes.com/news/fda-addresses-benefitrisk-framework-for-evaluating-opioid-analgesics The goal, according to agency officials, is to ensure product approval and removal decisions are science-based and that the agency&rsquo;s benefit-risk framework considers not only the outcomes of prescription opioids when used as prescribed, but also the public health effects of inappropriate use. Thu, 20 Jun 19 18:22:00 +0000 First Small Cell Lung Cancer Indication for Pembrolizumab Granted FDA Approval http://www.pharmacytimes.com/news/first-small-cell-lung-cancer-indication-for-pembrolizumab-granted-fda-approval http://www.pharmacytimes.com/news/first-small-cell-lung-cancer-indication-for-pembrolizumab-granted-fda-approval Pembrolizumab is already an established treatment option for non-small cell lung cancer, with several approved indications for its use in the disease. Tue, 18 Jun 19 14:22:00 +0000 FDA OKs Fifth Biosimilar to Trastuzumab http://www.pharmacytimes.com/news/fda-oks-fifth-biosimilar-to-trastuzumab http://www.pharmacytimes.com/news/fda-oks-fifth-biosimilar-to-trastuzumab Officials with the FDA approved Amgen&rsquo;s trastuzumab-anns, also known as ABP 980 (Kanjinti), the fifth FDA-approved biosimilar referencing trastuzumab (Herceptin).<br /> &nbsp; Thu, 13 Jun 19 20:10:00 +0000 Risk of Pediatric Shingles Reduced by Varicella Vaccine, Study Finds http://www.pharmacytimes.com/news/risk-of-pediatric-shingles-reduced-by-varicella-vaccine-study-finds- http://www.pharmacytimes.com/news/risk-of-pediatric-shingles-reduced-by-varicella-vaccine-study-finds- A new study finds duel benefit of the varicella vaccine Wed, 12 Jun 19 16:01:00 +0000 Vitamin K Helps, Not Harms Patients on Warfarin http://www.pharmacytimes.com/news/vitamin-k-helps-not-harms-patients-on-warfarin http://www.pharmacytimes.com/news/vitamin-k-helps-not-harms-patients-on-warfarin The trial analyzed the impact of vitamin K intake on patients who were taking warfarin to decrease the risk of blood clots. Wed, 12 Jun 19 13:05:00 +0000 FDA Approval: Polivy for Relapsed, Refractory Diffuse Large B-Cell Lymphoma http://www.pharmacytimes.com/news/fda-approves-polivy-for-relapsed-refractory-diffuse-large-bcell-lymphoma http://www.pharmacytimes.com/news/fda-approves-polivy-for-relapsed-refractory-diffuse-large-bcell-lymphoma Tue, 11 Jun 19 16:40:00 +0000 Neostigmine Methylsulfate Injection Ready-to-Fill Syringes Launched http://www.pharmacytimes.com/news/neostigmine-methylsulfate-injection-readytofill-syringes-launched http://www.pharmacytimes.com/news/neostigmine-methylsulfate-injection-readytofill-syringes-launched The Neostigmine Methylsulfate Injection is the first manufacturer-prepared, ready-to-administer prefilled syringe on the market. Mon, 10 Jun 19 20:09:00 +0000 New Program Provides Emergency Medicine Certificate to Pharmacists http://www.pharmacytimes.com/news/new-program-provides-emergency-medicine-certificate-to-pharmacists http://www.pharmacytimes.com/news/new-program-provides-emergency-medicine-certificate-to-pharmacists This course focuses on the application of evidence-based pharmacologic and nonpharmacologic therapies for clinical scenarios frequently encountered in the emergency department. Thu, 06 Jun 19 17:28:00 +0000 Generic Treatment for Parkinson Disease Receives FDA Approval http://www.pharmacytimes.com/news/generic-treatment-for-parkinson-disease-receives-fda-approval http://www.pharmacytimes.com/news/generic-treatment-for-parkinson-disease-receives-fda-approval The drug is therapeutically equivalent to Merck&rsquo;s Sinemet CR Tablets, 25 mg/100 mg and 50 mg/200 mg. Thu, 06 Jun 19 17:00:00 +0000